An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia
Condition(s):SchizophreniaLast Updated:July 31, 2014Completed
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:July 31, 2014Completed
Condition(s):Emergence DeliriumLast Updated:January 13, 2021Unknown status
Condition(s):Solid Tumor and Hematologic MalignanciesLast Updated:February 21, 2021Completed
Condition(s):Hypoxic-Ischemic Encephalopathy; Perinatal AsphyxiaLast Updated:October 23, 2023Recruiting
Condition(s):Heart FailureLast Updated:December 22, 2020Completed
Condition(s):Iron Deficiency Anaemia; Iron Deficiency Anemia; Chronic Kidney DiseaseLast Updated:October 6, 2020Completed
Condition(s):Iron Deficiency Anaemia; Iron Deficiency AnemiaLast Updated:October 6, 2020Completed
Condition(s):Vasodilation; VasoconstrictionLast Updated:March 23, 2023Completed
Condition(s):Intraocular Pressure; AnesthesiaLast Updated:December 7, 2016Completed
Condition(s):Tardive DyskinesiaLast Updated:September 12, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.